(Q34989060)

5 August 2017

Receptor conversion in distant breast cancer metastases (English)

1 reference

5 August 2017

1 reference

1 reference

15

Paul J van Diest

1 reference

5 August 2017

14

Elsken van der Wall

1 reference

5 August 2017

12

Petra van der Groep

1 reference

5 August 2017

Laurien D C Hoefnagel

1

1 reference

5 August 2017

Marc J van de Vijver

2

1 reference

5 August 2017

Henk-Jan van Slooten

3

1 reference

5 August 2017

Pieter Wesseling

4

1 reference

5 August 2017

Jelle Wesseling

5

1 reference

5 August 2017

Pieter J Westenend

6

1 reference

5 August 2017

Joost Bart

7

1 reference

5 August 2017

Cornelis A Seldenrijk

8

1 reference

5 August 2017

Iris D Nagtegaal

9

1 reference

5 August 2017

Joost Oudejans

10

1 reference

5 August 2017

Paul van der Valk

11

1 reference

5 August 2017

Elisabeth G E de Vries

13

1 reference

5 August 2017

23 September 2010

1 reference

5 August 2017

Breast Cancer Research

1 reference

5 August 2017

12

1 reference

5 August 2017

5

1 reference

5 August 2017

R75

1 reference

https://scigraph.springernature.com/pub.10.1186/bcr2645

5 August 2017

0 references

cites work

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

Molecular imaging of breast cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

PET imaging of steroid receptor expression in breast and prostate cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

Metallographic in situ hybridization

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

HER2 gene status in primary breast cancers and matched distant metastases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

The changing global patterns of female breast cancer incidence and mortality

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

No consent should be needed for using leftover body material for scientific purposes. For.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

Multiple estrogen receptor assays in human breast cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

Immunohistochemical detection of estrogen receptors in paraffin sections from primary and metastatic breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

Growth dominance of the metastatic cancer cell: cellular and molecular aspects

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

Variation in receptor status between primary and metastatic breast cancer.

8 July 2018

1 reference

Progesterone receptor status of breast cancer metastases

21 January 2018

1 reference

Impact of metastatic estrogen receptor and progesterone receptor status on survival

21 January 2018

1 reference

Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies

21 January 2018

1 reference

HER-2/neu expression in primary and metastatic breast cancer

21 January 2018

1 reference

Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

21 January 2018

1 reference

Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers.

21 January 2018

1 reference

HER-2/neu Status in Breast Cancer Metastases to the Central Nervous System

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

erbB-2 (HER-2) and breast cancer progression.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

Amplification of HER-2/neu and topoisomerase IIalpha in primary and metastatic breast cancer.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096964

Estrogen and progesterone receptor concordance between primary and recurrent breast cancer

26 October 2018

1 reference

12 December 2020

Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma

1 reference

12 December 2020

HER-2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy

1 reference

12 December 2020

c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues

1 reference

12 December 2020

Assessment of Her-2/neu overexpression in primary breast cancers and their metastatic lesions: an immunohistochemical study

1 reference

12 December 2020

Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

1 reference

12 December 2020

Identifiers

DOI

10.1186/BCR2645

1 reference

Dimensions Publication ID

5 August 2017

0 references

0 references

1 reference

5 August 2017

1 reference